114 related articles for article (PubMed ID: 28939161)
1. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
[TBL] [Abstract][Full Text] [Related]
2. MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs).
Joh J; Ghim SJ; Chilton PM; Sundberg JP; Park J; Wilcher SA; Proctor ML; Bennett Jenson A
Exp Mol Pathol; 2016 Feb; 100(1):212-9. PubMed ID: 26778691
[TBL] [Abstract][Full Text] [Related]
3. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.
Sundberg JP; Stearns TM; Joh J; Proctor M; Ingle A; Silva KA; Dadras SS; Jenson AB; Ghim SJ
PLoS One; 2014; 9(12):e113582. PubMed ID: 25474466
[TBL] [Abstract][Full Text] [Related]
4. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
5. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
6. Immunity to commensal papillomaviruses protects against skin cancer.
Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid metabolism proteins are altered in trichoblastomas induced by mouse papillomavirus 1.
Everts HB; Suo L; Ghim S; Bennett Jenson A; Sundberg JP
Exp Mol Pathol; 2015 Dec; 99(3):546-51. PubMed ID: 26416148
[TBL] [Abstract][Full Text] [Related]
8. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
9. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
10. Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.
Wang W; Uberoi A; Spurgeon M; Gronski E; Majerciak V; Lobanov A; Hayes M; Loke A; Zheng ZM; Lambert PF
PLoS Pathog; 2020 Jan; 16(1):e1008206. PubMed ID: 31968015
[TBL] [Abstract][Full Text] [Related]
11. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
12. Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining.
Yu L; Majerciak V; Xue XY; Uberoi A; Lobanov A; Chen X; Cam M; Hughes SH; Lambert PF; Zheng ZM
PLoS Pathog; 2021 Aug; 17(8):e1009812. PubMed ID: 34343212
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic poliovirus therapy and immunization with poliovirus-infected cell lysate induces potent antitumor immunity against neuroblastoma in vivo.
Toyoda H; Wimmer E; Cello J
Int J Oncol; 2011 Jan; 38(1):81-7. PubMed ID: 21109928
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
[TBL] [Abstract][Full Text] [Related]
15. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
[TBL] [Abstract][Full Text] [Related]
16. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
Virology; 2016 Jan; 488():73-80. PubMed ID: 26609937
[TBL] [Abstract][Full Text] [Related]
17. EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO.
Stubenrauch F; Straub E; Klein K; Kramer D; Iftner T; Wong M; Roden RBS
J Virol; 2021 Mar; 95(8):. PubMed ID: 33472931
[TBL] [Abstract][Full Text] [Related]
18. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
19. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
[TBL] [Abstract][Full Text] [Related]
20. Rodent Papillomaviruses.
Uberoi A; Lambert PF
Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]